Skip to main content
SpringerLink
Log in

Pharmacology and Pharmacokinetics of Opioids in the ICU

  • Chapter
  • First Online:
Opioid Use in Critical Care

  • 893 Accesses

Abstract

According to the 2018 Society of Critical Care Medicine (SCCM) guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption (PADIS), opioids are the cornerstone of pain management in critically ill patients. Nonetheless, multimodal analgesia is recommended to reduce opioid utilization and associated adverse outcomes (Devlin et al. Crit Care Med. 46:e825–73, 2018). In order to minimize adverse effects, the use of opioids in critically ill patients requires careful consideration of potential changes in pharmacokinetics and pharmacodynamics when selecting the appropriate agent, dose, and route of administration. This chapter will provide an overview of opioid pharmacology, dosing strategies, route of administration, adverse effects, and expected pharmacokinetic alterations in the critically ill.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pathan H, Williams J. Basic opioid pharmacology: an update. Br J Pain. 2012;6(1):11–6. https://doi.org/10.1177/2049463712438493.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Trivedi M, Shaikh S, Gwinnut G. Pharmacology of opioids. Update in Anaesthesia. 2008 [updated 2008 Feb 24; cited 2019 Nov 14]. Available from www.wfsahq.org.

  3. Fraser GL, Gagnon DJ. Pain and analgesia. CCSAP. 2016 [cited 2019 Nov 14]. Available from www.accp.com.

  4. Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician. 2008;11(2 Suppl):S133–53.

    Article  PubMed  Google Scholar 

  5. Drewes AM, Jensen RD, Nielsen LM, Droney J, Christrup LL, Arendt-Nielsen L, et al. Differences between opioids: pharmacological, experimental, clinical and economical perspectives. Br J Clin Pharmacol. 2013;75(1):60–78. https://doi.org/10.1111/j.1365-2125.2012.04317.x.

    Article  CAS  PubMed  Google Scholar 

  6. Lexicomp Online. Hudson. Ohio: Wolters Kluwer Clinical Drug Information, Inc; 2013. Accessed on November 13, 2019

    Google Scholar 

  7. Böhm R, Proksch E, Schwarz T, et al. Drug hypersensitivity. Dtsch Arztebl Int. 2018;115:501–12.

    PubMed  PubMed Central  Google Scholar 

  8. Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician. 2008;11:S105–20.

    Article  PubMed  Google Scholar 

  9. Swegle JM, Logemann C. Management of common opioid-induced adverse effects. Am Fam Physician. 2006;74:1347–54.

    PubMed  Google Scholar 

  10. Treillet E, Laurent S, Hadjiat Y. Practical management of opioid rotation and equianalgesia. J Pain Res. 2018;11:2587–601.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Barke KE, Hough LB. Opiates, mast cells and histamine release. Life Sci. 1993;53:1391–9.

    Article  CAS  PubMed  Google Scholar 

  12. Kalangara J, Potru S, et al. Clinical manifestations and diagnostic evaluation of opioid allergy labels: a review. J Pain Palliat Care Pharmacother. 2019; https://doi.org/10.1080/15360288.2019.1666955. [Epub ahead of print]

  13. Baldo BA, Pham NH. Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two. Anaesth Intensive Care. 2012;40:216–35.

    Article  CAS  PubMed  Google Scholar 

  14. Li PH, Ue KL, et al. Opioid hypersensitivity: predictors of allergy and role of drug provocation testing. J Allergy Clin Immunol Pract. 2017;5:1601–6.

    Article  CAS  PubMed  Google Scholar 

  15. Powell MZ, Mueller SW, et al. Assessment of opioid cross-reactivity and provider perceptions in hospitalized patients with reported opioid allergies. Ann Pharmacother. 2019;53:1117–23.

    Article  PubMed  Google Scholar 

  16. Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30(1):119–41.

    Article  PubMed  Google Scholar 

  17. Bruera E, Belzile M, Pituskin E, et al. Opioid rotation in patients with cancer pain. Cancer. 1996;78:852–7.

    Article  CAS  PubMed  Google Scholar 

  18. Dunbar PJ, Chapman CR, Buckley FP, et al. Clinical analgesic equivalence for morphine and hydromorphone with prolonged PCA. Pain. 1996;68:165–70.

    Article  Google Scholar 

  19. Fine PG, Portenoy RK. Establishing “best practices” for opioid rotation: conclusions of an expert panel. J Pain Symptom Manag. 2009;38:418–25.

    Article  Google Scholar 

  20. Ripamonti C, De Conno F, Groff L, et al. Equi-analgesic dose ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences. Ann Oncol. 1998;9:79–83.

    Article  CAS  PubMed  Google Scholar 

  21. Barr J, Fraser GL, Puntillo K, Ely EW, Gélinas C, Dasta JF, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306. https://doi.org/10.1097/CCM.0b013e3182783b72.

    Article  PubMed  Google Scholar 

  22. Devlin JW, Roberts RJ. Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids. Crit Care Clin. 2009;25(3):431–49., vii. https://doi.org/10.1016/j.ccc.2009.03.003.

    Article  CAS  PubMed  Google Scholar 

  23. Erstad BL, Puntillo K, Gilbert HC, Grap MJ, Li D, Medina J, et al. Pain management principles in the critically ill. Chest. 2009;135(4):1075–86. https://doi.org/10.1378/chest.08-2264.

    Article  PubMed  Google Scholar 

  24. Tse AHW, Ling L, Lee A, Joynt GM. Altered pharmacokinetics in prolonged infusions of sedatives and analgesics among adult critically ill patients: a systematic review. Clin Ther. 2018;40(9):1598–1615.e2. https://doi.org/10.1016/j.clinthera.2018.07.021. Epub 2018 Aug 31

    Article  CAS  PubMed  Google Scholar 

  25. Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, et al. Management of Postoperative Pain: a clinical practice guideline from the American pain society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ committee on regional Anesthesia, executive committee, and administrative council. J Pain. 2016;17(2):131–57. https://doi.org/10.1016/j.jpain.2015.12.008.

    Article  PubMed  Google Scholar 

  26. Stewart D. Pearls and pitfalls of patient-controlled analgesia. U.S. Pharmacists. 2017 [updated 2007 Mar 17; cited 2019 Nov 14]. Available from www.uspharmacist.com.

  27. Kruer RM, Jarrell AS, Latif A. Reducing medication errors in critical care: a multimodal approach. Clin Pharmacol. 2014;6:117–26. https://doi.org/10.2147/CPAA.S48530. eCollection 2014

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kestenbaum MG, Vilches AO, Messersmith S, Connor SR, Fine PG, Murphy B, et al. Alternative routes to oral opioid administration in palliative care: a review and clinical summary. Pain Med. 2014;15(7):1129–53. https://doi.org/10.1111/pme.12464. Epub 2014 Jul 4.

    Article  PubMed  Google Scholar 

  29. Bujedo BM. Spinal opioid bioavailability in postoperative pain. Pain Pract. 2014;14(4):350–64. https://doi.org/10.1111/papr.12099. Epub 2013 Jul 8

    Article  PubMed  Google Scholar 

  30. Mugabure BB. A clinical approach to neuraxial morphine for the treatment of postoperative pain. Pain Res Treat. 2012;2012:612145. Epub 2012 Jul 2

    Google Scholar 

  31. Kumar K, Singh SI. Neuraxial opioid-induced pruritus: An update. J Anaesthesiol Clin Pharmacol. 2013;29(3):303–7. https://doi.org/10.4103/0970-9185.117045.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Duramorph package insert. Deerfield, IL: Baxter Healthcare Corporation; 2005 [cited 2019 Nov 14]. Available from: www.accessdata.gov.gov.

  33. DeSousa KA, Chandran R. Intrathecal morphine for postoperative analgesia: current trends. World J Anaesth. 2014;3(3):191–202. https://doi.org/10.5313/wja.v3.i3.191.

    Article  Google Scholar 

  34. Hindle A. Intrathecal opioids in the management of acute postoperative pain. Cont Educ Anaesth Crit Care Pain. 2008;8(3):81–5. https://doi.org/10.1093/bjaceaccp/mkn016.

    Article  Google Scholar 

  35. Bernards CM, Shen DD, Sterling ES, Adkins JE, Risler L, Phillips B, et al. Epidural, cerebrospinal fluid, and plasma pharmacokinetics of epidural opioids (part 1): differences among opioids. Anesthesiology. 2003;99(2):455–65.

    Article  CAS  PubMed  Google Scholar 

  36. Bajaj S, Whiteman A, Brander B. Transdermal drug delivery in pain management. Cont Educ Anaesth Crit Care Pain. 2011;11:39–43. https://doi.org/10.1093/bjaceaccp/mkq054.

    Article  Google Scholar 

  37. Institute of Safe Medication Practices (ISMP). Fentanyl patches. 2013 [cited 2019 Nov 14]. Available from: https://www.ismp.org/sites/default/files/attachments/2018-11/fentanyl1-13.pdf.

  38. Margetts L, Sawyer R. Transdermal drug delivery: principles and opioid therapy. Cont Educ Anaesth Crit Care Pain. 2007;7:5:171–6. https://doi.org/10.1093/bjaceaccp/mkm033.

    Article  Google Scholar 

  39. Heiskanen T, Mätzke S, Haakana S, Gergov M, Vuori E, Kalso E. Transdermal fentanyl in cachectic cancer patients. Pain. 2009;144(1–2):218–22. https://doi.org/10.1016/j.pain.2009.04.012. Epub 2009 May 12

    Article  CAS  PubMed  Google Scholar 

  40. Carter KA. Heat-associated increase in transdermal fentanyl absorption. Am J Health Syst Pharm. 2003;60(2):191–2.

    Article  PubMed  Google Scholar 

  41. Institute of Safe Medication Practices (ISMP). ISMP Calls for more action to safeguard pain patches. 2005 [cited 2019 Nov 14]. Available from: https://www.ismp.org/news/ismp-calls-more-action-safeguard-pain-patches.

  42. American Pharmacists Association (APhA). The danger with cutting medication patches. 2013 [cited 2019 Nov 14]. Available at: https://www.pharmacist.com/danger-cutting-medication-patches.

  43. Compound summary. National Institutes of Health U.S. National library of medicine national center for biotechnology information. Accessed November 14, 2019. Available from: https://pubchem.ncbi.nlm.nih.gov/.

  44. Dayer P, Desmeules J, Collart L. Pharmacology of tramadol. Drugs. 1997;53(Suppl 2):18–24.

    Article  CAS  PubMed  Google Scholar 

  45. Opana package insert. Chadds Ford, PA: Endo Pharmaceuticals; 2011 Aug [cited 2019 Nov 14]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021611s007lbl.pdf.

  46. Opana ER package insert. Chadds Ford, PA: Endo Pharmaceuticals; 2012 [cited 2019 Nov 14].

    Google Scholar 

  47. Sloan P. Review of oral oxymorphone in the management of pain. Ther Clin Risk Manag. 2008;4(4):777–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Talwin package insert. Bridgewater, NJ: Sanofi-Aventis; 2011 [cited 2019 Nov 14]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018733s015lbl.pdf.

  49. Boucher BA, Wood GC, Swanson JM. Pharmacokinetic changes in critical illness. Crit Care Clin. 2006;22(2):255–71.

    Article  CAS  PubMed  Google Scholar 

  50. Choi L, Ferrell BA, Vasilevskis EE, Pandharipande PP, Heltsley R, Ely EW, et al. Population pharmacokinetics of fentanyl in the critically ill. Crit Care Med. 2016;44(1):64–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Mercadante S, Arcuri E. Opioids and renal function. J Pain. 2004;5(1):2–19.

    Article  CAS  PubMed  Google Scholar 

  52. Bosilkovska M, Walder B, Besson M, et al. Analgesics in patients with hepatic impairment. Drugs. 2012;72:1645–69.

    Article  CAS  PubMed  Google Scholar 

  53. De Paepe P, Belpaire FM, Buylaert WA. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock. Clin Pharmacokinet. 2002;41(14):1135–51.

    Article  PubMed  Google Scholar 

  54. Gelot S, Nakhla E. Opioid dosing in renal and hepatic impairment. US Pharm. 2014;39:34–8.

    Google Scholar 

  55. Ishizu H, Shioni S, Kawamura E, et al. Gastric emptying in patients with chronic liver diseases. Ann Nucl Med. 2002;16:177–82.

    Article  PubMed  Google Scholar 

  56. Delcò F, Tchambaz L, Schlienger R, et al. Dose adjustment in patients with liver disease. Drug Saf. 2005;28:529–45.

    Article  PubMed  Google Scholar 

  57. Lin S, Smith BS. Drug dosing considerations for the critically ill patient with liver disease. Crit Care Nurs Clin North Am. 2010;22:335–40.

    Article  PubMed  Google Scholar 

  58. Yogaratnam D, Ditch K, Medeiros K, et al. The impact of liver and renal dysfunction on the pharmacokinetics and pharmacodynamics of sedative and analgesic drugs in critically ill adult patients. Crit Care Nurs Clin North Am. 2016;28:183–4.

    Article  PubMed  Google Scholar 

  59. Beakley BD, Kaye AM, Kaye AD. Tramadol, pharmacology, side effects, and serotonin syndrome: a review. Pain Physician. 2015;18:395–400.

    PubMed  Google Scholar 

  60. Smith HS. Opioid metabolism. Mayo Clin Proc. 2009;84:613–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2013;62(16):e147–239. https://doi.org/10.1016/j.jacc.2013.05.019. Epub 2013 Jun 5

    Article  PubMed  Google Scholar 

  62. Ogawa R, Stachnik JM, Echizen H. Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 1, drugs administered intravenously). Clin Pharmacokinet. 2013;52(3):169–85. https://doi.org/10.1007/s40262-012-0029-2.

    Article  CAS  PubMed  Google Scholar 

  63. Dagan O, Klein J, Bohn D, Barker G, Koren G. Morphine pharmacokinetics in children following cardiac surgery: effects of disease and inotropic support. J Cardiothorac Vasc Anesth. 1993;7(4):396–8.

    Article  CAS  PubMed  Google Scholar 

  64. Naito K, Kohno T, Fukuda K. Harmful impact of morphine use in acute heart failure. J Thorac Dis. 2017;9(7):1831–4. https://doi.org/10.21037/jtd.2017.06.78.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Miró Ò, Gil V, Martín-Sánchez FJ, Herrero-Puente P, Jacob J, Mebazaa A, et al. Morphine use in the ED and outcomes of patients with acute heart failure: a propensity score-matching analysis based on the EAHFE registry. Chest. 2017;152(4):821–32. https://doi.org/10.1016/j.chest.2017.03.037. Epub 2017 Apr 12

    Article  PubMed  Google Scholar 

  66. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(27):2129–200. https://doi.org/10.1093/eurheartj/ehw128. Epub 2016 May 20

    Article  PubMed  Google Scholar 

  67. MacKenzie M, Zed PJ, Ensom MHH. Opioid pharmacokinetics-pharmacodynamics: clinical implications in acute pain management in trauma. Ann Pharmacother. 2016;50(3):209–1.

    Article  CAS  PubMed  Google Scholar 

  68. Bittner EA, Shank E, Woodson L, Martyn JA. Acute and perioperative care of the burn-injured patient. Anesthesiology. 2015;122(2):448–64. https://doi.org/10.1097/ALN.0000000000000559.

    Article  PubMed  Google Scholar 

  69. Gregoretti C, Decaroli D, Piacevoli Q, Mistretta A, Barzaghi N, Luxardo N, et al. Analgo-sedation of patients with burns outside the operating room. Drugs. 2008;68(17):2427–43. https://doi.org/10.2165/0003495-200868170-00003.

    Article  CAS  PubMed  Google Scholar 

  70. Griggs C, Goverman J, Bittner EA, Levi B. Sedation and pain management in burn patients. Clin Plast Surg. 2017;44(3):535–40. https://doi.org/10.1016/j.cps.2017.02.026. Epub 2017 Apr 18

    Article  PubMed  PubMed Central  Google Scholar 

  71. Blanchet B, Jullien V, Vinsonneau C, Tod M. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients. Clin Pharmacokinet. 2008;47(10):635–54.

    Article  CAS  PubMed  Google Scholar 

  72. Kaneda K, Han TH. Comparative population pharmacokinetics of fentanyl using non-linear mixed effect modeling: burns vs. non-burns. Burns. 2009;35(6):790–7. https://doi.org/10.1016/j.burns.2008.12.006. Epub 2009 Jun 6

    Article  PubMed  Google Scholar 

  73. Perreault S, Choinière M, du Souich PB, Bellavance F, Beauregard G. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries. Ann Pharmacother. 2001;35(12):1588–92.

    Article  CAS  PubMed  Google Scholar 

  74. Denson DD, Concilus RR, Warden G, Raj PP. Pharmacokinetics of continuous intravenous infusion of methadone in the early post-burn period. J Clin Pharmacol. 1990;30(1):70–5.

    Article  CAS  PubMed  Google Scholar 

  75. Dzierba AL, Abrams D, Brodie D. Medicating patients during extracorporeal membrane oxygenation: the evidence is building. Crit Care. 2017;21(1):66. https://doi.org/10.1186/s13054-017-1644-y.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Satyapriya SV, Lyaker ML, Rozycki AJ. Sedation, analgesia, delirium in the ECMO patient. Extracorporeal membrane oxygenation. In: Firstenberg MS, editor. Extracorporeal membrane oxygenation; 2016. https://doi.org/10.5772/64249. Available from: https://www.intechopen.com/books/extracorporeal-membrane-oxygenation-advances-in-therapy/sedation-analgesia-delirium-in-the-ecmo-patient.

    Chapter  Google Scholar 

  77. Ha MA, Sieg AC. Evaluation of altered drug pharmacokinetics in critically ill adults receiving extracorporeal membrane oxygenation. Pharmacotherapy. 2017;37(2):221–35. https://doi.org/10.1002/phar.1882. Epub 2017 Feb 3.

    Article  PubMed  Google Scholar 

  78. Shekar K, Roberts JA, Mcdonald CI, Ghassabian S, Anstey C, Wallis SC, et al. Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study. Crit Care. 2015;19:164. https://doi.org/10.1186/s13054-015-0891-z.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Heith CS, Hansen LA, Bakken RM, Ritter SL, Long BR, Hume JR, et al. Effects of an ex vivo pediatric extracorporeal membrane oxygenation circuit on the sequestration of Mycophenolate Mofetil, Tacrolimus, Hydromorphone, and Fentanyl. J Pediatr Pharmacol Ther. 2019;24(4):290–5. https://doi.org/10.5863/1551-6776-24.4.290.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Shekar K, Roberts JA, Ghassabian S, Mullany DV, Ziegenfuss M, Smith MT, et al. Sedation during extracorporeal membrane oxygenation-why more is less. Anaesth Intensive Care. 2012;40(6):1067–9.

    CAS  PubMed  Google Scholar 

  81. Shekar K, Roberts JA, McDonald CI, Fisquet S, Barnett AG, Mullany DV, et al. Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation. Crit Care. 2012;16(5):R194. https://doi.org/10.1186/cc11679.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Cheng V, Abdul-Aziz MH, Roberts JA, Shekar K. Optimising drug dosing in patients receiving extracorporeal membrane oxygenation. J Thorac Dis. 2018;10(Suppl 5):S629–41. https://doi.org/10.21037/jtd.2017.09.154.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Astle S. Pain management in critically ill obese patients. Crit Care Nurs Clin North Am. 2009;21(3):323–39.

    Article  PubMed  Google Scholar 

  84. Shibutani K, Inchiosa MA, Sawada K, Bairamian M. Accuracy of pharmacokinetic models for predicting plasma fentanyl concentrations in lean and obese surgical patients: derivation of dosing weight (“pharmacokinetic mass”). Anesthesiology. 2004;101:603–13.

    Article  CAS  PubMed  Google Scholar 

  85. Cheymol G. Effects of obesity on pharmacokinetics: implications for drug therapy. Clin Pharmacokinet. 2000;39(3):215–31.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD, USA

    Jessica R. Crow & Stephanie L. Davis

  2. Department of Pharmacy, Oregon Health & Science University, Portland, OR, USA

    Andrew S. Jarrell

Authors
  1. Jessica R. Crow
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephanie L. Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew S. Jarrell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jessica R. Crow .

Editor information

Editors and Affiliations

  1. Professor of Surgery and Neurosurgery, Perelman School of Medicine Clinical Associate, School of Nursing, University of Pennsylvania, Philadelphia, PA, USA

    Jose L. Pascual

  2. Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

    Timothy G. Gaulton

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Crow, J.R., Davis, S.L., Jarrell, A.S. (2021). Pharmacology and Pharmacokinetics of Opioids in the ICU. In: Pascual, J.L., Gaulton, T.G. (eds) Opioid Use in Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-030-77399-1_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-77399-1_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-77398-4

  • Online ISBN: 978-3-030-77399-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation